Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
11/1995
11/30/1995WO1995032218A1 Neurotensin antagonist peptides
11/30/1995WO1995032217A1 Peptide antagonist intermediates of neurotensin
11/29/1995EP0683792A1 Lhrh antagonists having modified aminoacyl residues at postions 5 and 6
11/29/1995EP0359783B1 Treatment of autoimmune diseases by oral administration of autoantigens
11/28/1995US5470953 Human β2 integrin α subunit
11/28/1995US5470952 Interleukin antagonists
11/28/1995US5470950 Biologically active amphiphilic peptide compositions and uses therefor
11/28/1995US5470948 Vasopressin and vasotocin derivatives
11/28/1995US5470947 CHRH antagonists with low histamine release
11/28/1995US5470831 Angiogenic peptides
11/28/1995US5470830 Motilin-like polypeptides that inhibit gastrointestinal motor activity
11/28/1995US5470827 Method of producing iturin A and antifungal agent for profound mycosis
11/23/1995WO1995031480A1 Heterodimer polypeptide immunogen carrier composition and method
11/23/1995WO1995031475A1 Inhibition of liver cancer by the use of gnrh and gnrh analogs
11/23/1995WO1995031221A1 Somatostatin binding peptide-metal chelate conjugates
11/23/1995WO1995031210A1 Peptides and compounds that bind selectins including endothelium leukocyte adhesion molecule 1 (elam-1)
11/23/1995WO1995026981A3 Peptides having farnesyl transferase inhibiting properties and strain of genus streptomyces for producing same
11/23/1995CA2189978A1 Compounds for reversing drug resistance
11/23/1995CA2189326A1 Inhibition of liver cancer by the use of gnrh and gnrh analogs
11/22/1995EP0683173A1 Cyclic adhesion inhibitors
11/22/1995EP0682714A1 Novel neutrophil inhibitors
11/22/1995EP0682704A1 Phospho-specific antibodies against transcription factors, more specifically against a creb derived peptide
11/22/1995EP0682703A1 HTLV-I AND HTLV-II gp21 DERIVED PEPTIDES FOR USE IN DIAGNOSTICS
11/22/1995CN1112125A Acyloxyhexanoic acid derivatives
11/22/1995CN1112019A Novel process for the preparation of cetrorelix lyophilisate
11/21/1995US5468494 Polypeptides as anticarcinogenic agents
11/16/1995WO1995030775A1 High-affinity ligands of insulin receptor antibodies, tachykinin substance p, hiv integrase and hiv-1 reverse transcriptase
11/16/1995WO1995030694A1 New opioid peptide analogs with mixed mu agonist/delta antagonist properties
11/16/1995WO1995030691A1 New peptide active substance and production thereof
11/16/1995WO1995030690A1 Novel tetrapeptides, their manufacture and use
11/16/1995WO1995030430A1 Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent
11/16/1995WO1995028418A3 Tachykinin antagonists
11/16/1995DE4415344A1 Aurantimycin B peptide antibiotic
11/16/1995CA2188670A1 New opioid peptide analogs with mixed mu agonist/delta antagonist properties
11/15/1995EP0682257A1 Methods of detecting collagen degradation in vivo
11/15/1995EP0682256A1 Methods of detecting collagen degradation in vivo
11/15/1995EP0420913B1 Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same
11/15/1995CN1111640A Lipopeptide derivatives, a process for their preparation and their use
11/09/1995WO1995030009A2 Identification, production and use of saponin glyclosyl hydrolases
11/09/1995WO1995029708A1 TECHNETIUM-99m LABELED IMAGING AGENTS
11/09/1995WO1995017678A3 Differentiation of htlv-i and htlv-ii using synthetic peptides
11/09/1995DE4415998A1 Neue Tetrapeptide, ihre Herstellung Verwendung New tetrapeptides, their preparation using
11/09/1995DE4415997A1 Neuer peptidischer Wirkstoff und dessen Herstellung New peptidic drug and its preparation
11/09/1995DE4415345A1 New peptide antibiotics helioferin A and B from Mycogone rosea
11/09/1995CA2189420A1 Technetium-99m labeled imaging agents
11/08/1995EP0680513A1 Lysosomal targeting of immunogens
11/08/1995CN1111455A Peptide inhibitors of mitogenesis and motorgenesis
11/08/1995CN1111237A Preparation of amides and peptides
11/07/1995US5464944 Synthetic antifungal peptides
11/07/1995US5464939 Highly purified protein, production and use thereof
11/07/1995US5464935 Peptide inhibitors of selectin binding
11/07/1995US5464934 Metal chelates as spacer compounds in biologically active peptides
11/07/1995US5464933 Synthetic peptide inhibitors of HIV transmission
11/07/1995US5464823 Mammalian antibiotic peptides
11/07/1995US5464821 And intraocular hypertension
11/07/1995US5464819 Physiologically active peptide having immunoregulatory activities
11/02/1995WO1995029194A1 Peptides as therapeutic agents for the treatment of auto-immune diseases
11/02/1995WO1995029191A1 Peptide fragments and analogs derived from pban 1-33 nh2 for controlling moths
11/02/1995WO1995029190A1 Multirepresentation of a peptide analogue of the dppiv substrate, especially of the kpr type, to inhibit the entry of hiv in cells
11/02/1995WO1995029189A1 FACTOR Xa INHIBITORS
11/02/1995WO1995028832A1 Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides
11/02/1995EP0679658A1 Endothelin-antagonizing peptide
11/02/1995EP0679092A1 Cytokine restraining agents
11/02/1995EP0679083A1 Prevention and treatment of sepsis
11/02/1995DE4413938A1 Peptide als Therapeutikum für Autoimmunerkrankungen Peptides as therapeutics for autoimmune diseases
11/02/1995CA2722364A1 Melanoma antigens
11/02/1995CA2188470A1 Multirepresentation of a peptide analogue of the dppiv substrate, especially of the kpr type, to inhibit the entry of hiv in cells
11/02/1995CA2188391A1 Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides
10/1995
10/31/1995US5462926 Inhibiting inositol phosphate by contacting cells with an octapeptide
10/31/1995US5462871 Nonapeptides bind to human leukocyte antigens on cell surfaces leading to lysis by cytolytic T lymphocytes
10/26/1995WO1995028426A2 Peptides for reducing or inhibiting bone resorption, angiogenesis and restenosis
10/26/1995WO1995028418A2 Tachykinin antagonists
10/26/1995WO1995028172A1 Human bone stimulating factor
10/26/1995WO1995028170A1 Icam-1/lfa-1 short-chain peptides and method of using same
10/26/1995CA2188287A1 Icam-1/lfa-1 short-chain peptides and method of using same
10/26/1995CA2188172A1 Human bone stimulating factor
10/26/1995CA2187642A1 Peptides for reducing or inhibiting bone resorption, angiogenesis and restenosis
10/26/1995CA2183991A1 Tachykinin antagonists
10/25/1995EP0678577A2 Method for the production of recombinant human LH-RH receptor proteins
10/25/1995EP0678100A1 Synthetic amphipathic peptides with antimicrobial activity
10/25/1995EP0678099A1 New peptides
10/25/1995EP0678018A1 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides
10/25/1995EP0433378B1 ALLELIC VARIANTS OF $i(PLASMODIUM FALCIPARUM) MEROZOITE SURFACE ANTIGEN
10/24/1995US5461035 Short peptides with insulin activity
10/24/1995US5460978 Protein active in humoral hypercalcemia of malignancy-PthrP
10/24/1995US5460801 Inhibition of small cell lung cancer cell growth in vivo using monoclonal antibody
10/24/1995US5460786 Cleaving peptied-solid support bond and removing side chain protecting groups
10/24/1995CA1337407C Dimeric peptides having a stimulatory effect on haemopoiesis and a process for their preparation
10/20/1995CA2147344A1 Receptor expression cells and use thereof
10/19/1995WO1995027901A1 Class i peptide binding motifs
10/19/1995WO1995027782A1 Peptide production as fusion protein in transgenic mammal milk
10/19/1995WO1995027731A1 Compound ge3
10/19/1995WO1995027730A1 New thiodepsipeptide isolated from a marine actinomycete
10/19/1995WO1995027728A1 Peptides
10/19/1995WO1995018855A3 Synthetic antimicrobial peptides
10/19/1995CA2187173A1 Peptide production as fusion protein in transgenic mammal milk
10/19/1995CA2164618A1 Compound ge3
10/18/1995EP0677117A1 Differentiation of htlv-i and htlv-ii using synthetic peptides
10/18/1995EP0677116A1 A process for producing immunosuppressives and a novel microbial species to be employed therein
10/18/1995EP0677061A1 Polypeptide and anti-hiv agent prepared therefrom
1 ... 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 ... 423